Home › Tyrogenex X-82 Poster Presentation at the 2015 American Society for...
 

Keywords :   


Tyrogenex X-82 Poster Presentation at the 2015 American Society for...

2015-05-31 01:52:06| Logistics - Topix.net

Tyrogenex, a leader in the development of novel kinase inhibitors to target angiogenesis, today announced that the University of Wisconsin presented a new trial concept of investigational agent X-82, as a "Trials in Progress" poster at the 51st Annuali 1 2Meeting of the American Society of Clinical Oncology in Chicago. The study titled, "Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel," focuses on the optimization of a VEGFR/PDGFR TKI in combination with docetaxel.

Tags: for american society presentation

Category:Transportation and Logistics

Latest from this category

All news
07.10Hurricane Milton Forecast Advisory Number 11
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Wind Speed Probabilities Number 22
07.10Summary for Hurricane Leslie (AT3/AL132024)
07.10Hurricane Leslie Public Advisory Number 22
07.10Hurricane Leslie Forecast Advisory Number 22
07.10Hurricane Milton Public Advisory Number 10A
07.10Atlantic Tropical Weather Outlook
Transportation and Logistics »
07.10Hurricane Milton Forecast Advisory Number 11
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Wind Speed Probabilities Number 22
07.10Hurricane Leslie Public Advisory Number 22
07.10Summary for Hurricane Leslie (AT3/AL132024)
07.10Hurricane Leslie Forecast Advisory Number 22
07.10Appvion expands EarthChem Portfolio with Alpha 185 E
07.10Additional beef supply starting to show
More »